Related Experiment Videos
Percutaneous coronary intervention for chronic total occlusions: improved survival for patients with successful
Shahid Aziz1, Rodney H Stables, Antony D Grayson
1Department of Cardiology, Royal Blackburn Hospital, Blackburn, Lancashire, United Kingdom. saziz1@bitinternet.com
Insights
Successful chronic total occlusion (CTO) revascularization via percutaneous coronary intervention (PCI) significantly improves patient survival. Failed CTO procedures are linked to higher mortality rates, highlighting the importance of successful revascularization.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Limited data exists on the survival impact of successful chronic total occlusion (CTO) revascularization using percutaneous coronary intervention (PCI).
- This study retrospectively compares survival outcomes between patients with successful and failed CTO revascularization.
- CTO is defined as an arterial occlusion present for at least 3 months with Thrombolysis in Myocardial Infarction (TIMI) flow grade 0 or 1.
Purpose of the Study:
- To evaluate the effect of successful CTO revascularization by PCI on patient survival.
- To compare mortality rates between patients who underwent successful versus failed CTO PCI procedures.
- To identify CTO failure as an independent predictor of mortality.
Main Methods:
- Retrospective analysis of 543 patients undergoing PCI for CTO between 2000 and 2004.
- Patient records were linked to a national database for mortality tracking.
- Propensity matching was employed to control for case mix differences between successful and failed CTO groups.
Main Results:
- Technical success rate for CTO PCI was 69.4% (377/543 patients).
- Mortality rates were significantly lower in the successful CTO PCI group (2.5% vs. 7.3% at 1.7 years follow-up).
- CTO failure was an independent predictor of death (adjusted hazard ratio 4.63).
Conclusions:
- Successful revascularization of CTO by PCI is associated with improved survival rates.
- Failed CTO PCI procedures are linked to a significantly higher risk of mortality.
- Achieving successful CTO revascularization is crucial for enhancing long-term patient outcomes.
Background:
There are limited data on the impact of successful chronic total occlusion (CTO) revascularization by percutaneous coronary intervention (PCI) on survival. We performed a retrospective study comparing the survival between patients with a successful and a failed CTO revascularization by PCI.
Methods:
Between January 1, 2000 and June 30, 2004, 543 of 5803 (9.4%) patients underwent PCI for a CTO at our center. A CTO was defined as an occlusion of the artery present for at least 3 months with Thrombolysis in Myocardial Infarction flow grade 0 or 1. Patient records were linked to a national database to monitor all deaths during follow up. Propensity matching was used to balance out case mix differences.
Results:
Technical success for CTO was 377 of 543 (69.4%). In-hospital mortality was 0.3% and 1.2% for the CTO success and CTO failure patients, respectively. During a mean (SD) follow up of 1.7 (0.5) years, the mortality rate was 2.5% in the CTO success patients and 7.3% in the CTO failure patients. The crude hazard ratio for death with CTO failure was 3.92 (95% confidence intervals 1.56-10.07; P = 0.004). The rates of coronary artery bypass were 3.2% vs. 21.7% (P < 0.001) for the CTO success and CTO failure patients, respectively. Our propensity matched 157 CTO success to CTO failure patients and the associated hazard ratio for death with CTO failure was 4.63 (95% confidence interval 1.01-12.61; P = 0.049). Multivariate analysis showed that CTO failure was an independent predictor of death.
Conclusion:
Patients with a successful revascularization of a CTO by PCI have an increased survival rate compared to patients with a failed CTO procedure.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies